Beyond biomarkers: an opportunity to address the 'pharmacodynamic gap' in pediatric drug development.
Gregory L
GL
Kearns
D054316:Biomarkers, Pharmacological; D003663:Decision Trees; D055808:Drug Discovery / Q000379:methods* / Q000639:trends; D023381:Endpoint Determination / Q000379:methods / Q000639:trends; D006801:Humans; D010372:Pediatrics; D014481:United States; D014486:United States Food and Drug Administration
D054316:Biomarkers, Pharmacological